osphos

Drug Maker Issues Statement Regarding Bisphosphonates: Unscrupulous Use ‘Morally Reprehensible’

Dechra Veterinary Products prides itself as a global leader in the ethical and responsible use of pharmaceuticals. The health of the horse is our first and foremost priority, and a driving force in our product development, commercialization and ongoing research efforts. We are passionate advocates of equine welfare and our people, science and products deliver […]

Continue reading
Bisphosphonates: What We Know About Off-Label Use, And What One Drug Company Is Doing About It

A little more than a year ago, top surgeon Dr. Larry Bramlage stood up in Rood and Riddle’s annual Client Education Seminar and issued a warning to attendees about a new group of drugs called bisphosphonates. Bramlage worried the drug was being misused, and that misuse was putting racehorses at serious, long-term risk of injury […]

Continue reading
CBA: ‘Off Label’ Use Of Bisphosphonates In Young Horses Is Unacceptable

The use of bisphosphonates in young horses is a hot-button issue with the recent rash of breakdowns at Santa Anita Park, and last week the Thoroughbred Horsemen’s Association began pushing for rules that would partially ban bisphosphonates. The drug, commercially known as Osphos or Tildren and used to treat  symptoms of navicular disease, is not […]

Continue reading
View From The Eighth Pole: Take Action Now On Bisphosphonates Use

“I’ve been Tildrened.” That’s what a consignor of 2-year-olds said recently to a leading owner about a horse he purchased at a yearling sale with the intention of putting it in training and re-selling it as a prospective racehorse this spring. He was referring to the potentially negative side-effects from a drug called Tildren, one […]

Continue reading
Twitter Twitter
Paulick Report on Instagram